XTNT vs. EXEL
XTNT (Xtant Medical Holdings, Inc.) and EXEL (Exelixis, Inc.) are both stocks. Both are in the Healthcare sector — XTNT in Medical Devices, EXEL in Biotechnology. Over the past 10 years, XTNT returned -33.02%/yr vs 20.91%/yr for EXEL. At a 0.04 correlation, their price movements are largely independent.
Performance
XTNT vs. EXEL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XTNT achieves a -44.39% return, which is significantly lower than EXEL's 17.16% return. Over the past 10 years, XTNT has underperformed EXEL with an annualized return of -33.02%, while EXEL has yielded a comparatively higher 20.91% annualized return.
XTNT
- 1D
- -1.04%
- 1M
- -9.17%
- YTD
- -44.39%
- 6M
- -46.17%
- 1Y
- -27.21%
- 3Y*
- -18.65%
- 5Y*
- -24.00%
- 10Y*
- -33.02%
EXEL
- 1D
- -1.08%
- 1M
- 2.39%
- YTD
- 17.16%
- 6M
- 11.17%
- 1Y
- 27.20%
- 3Y*
- 37.25%
- 5Y*
- 18.24%
- 10Y*
- 20.91%
XTNT vs. EXEL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XTNT Xtant Medical Holdings, Inc. | -44.39% | 76.98% | -60.80% | 71.21% | 17.86% | -53.18% | -25.24% | -0.62% | -76.56% | 4.09% |
EXEL Exelixis, Inc. | 17.16% | 31.62% | 38.81% | 49.56% | -12.25% | -8.92% | 13.90% | -10.42% | -35.30% | 103.89% |
Correlation
The correlation between XTNT and EXEL is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2015 | 0.04 |
Fundamentals
XTNT:
$0.09
EXEL:
$3.00
XTNT:
4.81
EXEL:
17.13
XTNT:
0.32
EXEL:
6.01
XTNT:
$133.93M
EXEL:
$2.38B
XTNT:
$84.27M
EXEL:
$1.70B
XTNT:
$22.15M
EXEL:
$991.79M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XTNT vs. EXEL — Risk / Return Rank
XTNT
EXEL
XTNT vs. EXEL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtant Medical Holdings, Inc. (XTNT) and Exelixis, Inc. (EXEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XTNT | EXEL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.14 | ||
| Sortino ratioReturn per unit of downside risk | -1.50 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.16 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.51 | 1.09 | -1.60 |
| Martin ratioReturn relative to average drawdown | -0.89 | 2.62 | -3.51 |
Loading charts...
Drawdowns
XTNT vs. EXEL - Drawdown Comparison
The maximum XTNT drawdown since its inception was -99.17%, roughly equal to the maximum EXEL drawdown of -97.38%. Use the drawdown chart below to compare losses from any high point for XTNT and EXEL.
Loading charts...
Drawdown Indicators
| XTNT | EXEL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.17% | -97.38% | -1.79% |
Max Drawdown (1Y)Largest decline over 1 year | -53.17% | -25.16% | -28.01% |
Max Drawdown (3Y)Largest decline over 3 years | -74.78% | -25.34% | -49.44% |
Max Drawdown (5Y)Largest decline over 5 years | -82.48% | -36.12% | -46.36% |
Max Drawdown (10Y)Largest decline over 10 years | -98.54% | -57.20% | -41.34% |
Current DrawdownCurrent decline from peak | -98.96% | -4.02% | -94.94% |
Average DrawdownAverage peak-to-trough decline | -88.79% | -70.97% | -17.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.48% | 10.42% | +20.06% |
Volatility
XTNT vs. EXEL - Volatility Comparison
The current volatility for Xtant Medical Holdings, Inc. (XTNT) is 7.99%, while Exelixis, Inc. (EXEL) has a volatility of 9.41%. This indicates that XTNT experiences smaller price fluctuations and is considered to be less risky than EXEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XTNT | EXEL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.99% | 9.41% | -1.42% |
Volatility (6M)Calculated over the trailing 6-month period | 32.96% | 25.55% | +7.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 59.68% | 40.36% | +19.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 73.65% | 37.19% | +36.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 113.47% | 44.49% | +68.98% |
Dividends
XTNT vs. EXEL - Dividend Comparison
Neither XTNT nor EXEL has paid dividends to shareholders.
Financials
XTNT vs. EXEL - Financials Comparison
This section allows you to compare key financial metrics between Xtant Medical Holdings, Inc. and Exelixis, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XTNT vs. EXEL - Profitability Comparison
XTNT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Xtant Medical Holdings, Inc. reported a gross profit of 17.75M and revenue of 32.36M. Therefore, the gross margin over that period was 54.9%.
EXEL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exelixis, Inc. reported a gross profit of 0.00 and revenue of 610.81M. Therefore, the gross margin over that period was 0.0%.
XTNT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Xtant Medical Holdings, Inc. reported an operating income of -944.00K and revenue of 32.36M, resulting in an operating margin of -2.9%.
EXEL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exelixis, Inc. reported an operating income of 251.34M and revenue of 610.81M, resulting in an operating margin of 41.2%.
XTNT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Xtant Medical Holdings, Inc. reported a net income of 4.06M and revenue of 32.36M, resulting in a net margin of 12.6%.
EXEL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exelixis, Inc. reported a net income of 210.47M and revenue of 610.81M, resulting in a net margin of 34.5%.
Frequently Asked Questions
XTNT and EXEL have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EXEL has higher volatility (9.41%) compared to XTNT (7.99%). In terms of maximum drawdown, XTNT dropped -99.17% vs EXEL's -97.38%.
EXEL currently has the higher Sharpe Ratio (0.68 vs -0.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XTNT and EXEL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer